| Study cohort, N = 1,362,284 | |
---|---|---|
Variable | n | % |
Age, years | ||
 20–44 | 735,384 | 54.0 |
 45–64 | 495,520 | 36.4 |
 65–74 | 82,146 | 6.0 |
 75+ | 49,234 | 3.6 |
 Mean (SD) | 44.0 | (15.2) |
Men | 659,112 | 48.4 |
Urbanization level | ||
 1 (most urbanized) | 359,435 | 26.4 |
 2 | 606,694 | 44.5 |
 3 | 232,680 | 17.1 |
 4–7 | 163,475 | 12.0 |
Income level, Taiwan dollarsa | ||
  < =272,470 | 432,566 | 31.8 |
 272,471–273,351 | 369,701 | 27.1 |
 273,351–311,566 | 338,977 | 24.9 |
  > 311,566 | 221,040 | 16.2 |
Comorbidityb | ||
 Diabetes | 80,181 | 5.9 |
 Hypertension | 171,447 | 12.6 |
 Hyperlipidemia | 113,536 | 8.3 |
 Coronary artery disease | 42,894 | 3.2 |
 Chronic obstructive pulmonary disease | 55,700 | 4.1 |
 Atrial fibrillation | 4054 | 0.3 |
Outcomes and follow-up | ||
 Person-years at risk | ||
  Total | 8,019,765 |  |
  Mean (Median) | 5.9 (6.0) |  |
 Number of events (Incidence)c |  |  |
  Total stroke | 12,942 (1.6) |  |
  Ischemic stroke | 9919 (1.2) |  |
  Hemorrhagic stroke | 3023 (0.4) |  |